Story thread · 2 reports / 2 sources
Olema Pharmaceuticals Shares Fall 15.1% Following AstraZeneca SERENA-4 Trial Results
finance.yahoo.com · 21h
First report: Olema drops after hours on AstraZeneca Etcamah data — seekingalpha.com, 3d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.